Author:
Holler Marina,Grottke Astrid,Mueck Katharina,Manes Julia,Jücker Manfred,Rodemann H. Peter,Toulany Mahmoud
Funder
Deutsche Forschungsgemeinschaft
Deutsche Forschungsgemeinschaft (DE)
Open Access Publishing Fund of University Tübingen
Publisher
Public Library of Science (PLoS)
Reference53 articles.
1. TOR signaling in growth and metabolism;S Wullschleger;Cell,2006
2. Upstream and downstream of mTOR;N Hay;Genes Dev,2004
3. The TOR pathway: a target for cancer therapy;MA Bjornsti;Nat Rev Cancer,2004
4. Ridaforolimus (AP23573; MK-8669), a potent mTOR inhibitor, has broad antitumor activity and can be optimally administered using intermittent dosing regimens;VM Rivera;Mol Cancer Ther,2011
5. mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer;K Yu;Endocr Relat Cancer,2001
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献